Materials and Methods: This retrospective study was a substudy of the screening program that was approved by the Dutch Ministry of Health, and all participants provided written informed consent. Two independent readers used semiautomated software to measure the volume of pulmonary nodules detected in 6774 participants aged 50–75 years (5917 men). Nodules were classified according to their location (purely intraparenchymal, pleural based, juxtavascular, or fissure attached), morphology (smooth, polylobulated, spiculated, or irregular), and size (≤50 mm³ or >50 mm³). The level of agreement was expressed by using the absolute values of the relative volume differences (RVDs). Multivariate logistic regression analysis was performed, and odds ratios (ORs) were computed to quantify the independent effects of morphology, location, and size on RVD categories.

Results: Altogether, 4225 nodules in 2239 participants were included. Complete agreement in volume was obtained for 3646 (86%) of the nodules. Disagreement was small (absolute value of RVD < 5%) for 173 (4%) nodules, moderate (absolute value of RVD ≥ 5% but < 15%) for 232 (6%), and large (absolute value of RVD ≥ 15%) for 174 (4%). Multivariate analysis showed that the ORs of volume disagreement were 15.7, 3.1, and 1.9 for irregular, spiculated, and polylobulated nodules, respectively; 3.5, 2.6, and 2.1 for juxtavascular, pleural-based, and fissure-attached nodules, respectively; and 1.3 for large nodules compared with smooth, purely intraparenchymal, and small reference nodules.

Conclusion: Nodule morphology, location, and size influence volume measurement variability, particularly for juxtavascular and irregular nodules.

© RSNA, 2008

Materials and Methods: Institutional review board approval and informed consent were obtained. The study included 165 patients (125 men, 40 women; mean age, 61 years) with NSCLC proved at pathologic examination who underwent both unenhanced PET/CT and whole-body MR imaging. Pathologic findings for T (n = 123) and N (n = 150) staging and pathologic or follow-up imaging findings (n = 154) for M staging were reference standards. The efficacies of PET/CT and whole-body MR imaging for lung cancer staging were compared by using the McNemar test.

Results: Primary tumors (n = 123 patients) were correctly staged in 101 (82%) patients at PET/CT and in 106 (86%) patients at whole-body MR imaging (P = .263). N stages (n = 150 patients) were correctly determined in 105 (70%) patients at PET/CT and in 102 (68%) patients at whole-body MR imaging (P = .880). Thirty-one (20%) of 154 patients had metastatic lesions. Accuracy for detecting metastases was 86% (133 of 154 patients) at PET/CT, and that at whole-body MR imaging was 86% (132 of 154 patients) (P > .99). Although the differences were not statistically significant, whole-body MR imaging was more useful for detecting brain and hepatic metastases, whereas PET/CT was more useful for detecting lymph node and soft-tissue metastases.

Conclusion: Both PET/CT and 3.0-T whole-body MR imaging appear to provide acceptable accuracy and comparable efficacy for NSCLC staging, but for M-stage determination, each modality has its own advantages.

© RSNA, 2008

Materials and Methods: The institutional review board approved this study; informed consent was obtained from patients. A total of 203 NSCLC patients (109 men, 94 women; mean age, 72 years) prospectively underwent whole-body DW imaging, whole-body MR imaging, and FDG PET/CT. Final diagnosis of the M-stage in each patient was determined on the basis of results of all radiologic and follow-up examinations. Two chest radiologists and two nuclear medicine physicians independently assessed all examination results and used a five-point visual scoring system to evaluate the probability of metastases. Final diagnosis based on each of the methods was made by consensus of two readers. Receiver operating characteristic (ROC) analysis was used to compare the capability for M-stage assessment among whole-body DW imaging, whole-body MR imaging with and that without DW imaging, and PET/CT on a per-patient basis. Sensitivity, specificity, and accuracy were compared with the McNemar test.

Results: Area under ROC curve (A_z) values of whole-body MR imaging with DW imaging (A_z = 0.87, P = .04) and integrated FDG PET/CT (A_z = 0.89, P = .02) were significantly larger than that of whole-body DW imaging (A_z = 0.79). Specificity and accuracy of whole-body MR imaging with (specificity, P = .02; accuracy, P < .01) and that without DW imaging (specificity, P = .02; accuracy, P = .01) and integrated FDG PET/CT (specificity, P < .01; accuracy, P < .01) were significantly higher than those of whole-body DW imaging.

Conclusion: Whole-body MR imaging with DW imaging can be used for M-stage assessment in NSCLC patients with accuracy as good as that of PET/CT.

© RSNA, 2008

Materials and Methods: Local institutional review board approval and informed consent were obtained. Physiologic monitoring data were obtained before, during, and after hyperpolarized ³He MR imaging in 100 consecutive subjects (57 men, 43 women; mean age, 52 years ± 14 [standard deviation]). The subjects inhaled 1–3 L of a gas mixture containing 300–500 mL ³He and 0–2700 mL N₂ and held their breath for up to 15 seconds during MR imaging. Heart rate and rhythm and oxygen saturation of hemoglobin as measured by pulse oximetry (Spo₂) were monitored continuously throughout each study. The effects of ³He MR imaging on vital signs and Spo₂ and the relationship between pulmonary function, number of doses, and clinical classification (healthy volunteers, patients with asthma, heavy smokers, patients undergoing lung volume reduction surgery for severe emphysema, and patients with lung cancer) and the lowest observed Spo₂ were assessed. Any subjective symptoms were noted.

Results: Except for a small postimaging decrease in mean heart rate (from 78 beats per minute ± 13 to 73 beats per minute ± 11, P < .001), there was no effect on vital signs. A mean transient decrease in Spo₂ of 4% ± 3 was observed during the first minute after gas inhalation (P < .001) in 77 subjects who inhaled a dose of 1 L for 10 seconds or less, reaching a nadir of less than 90% at least once in 20 subjects and of less than 85% in four subjects. There was no correlation between the lowest Spo₂ and pulmonary function parameters other than baseline Spo₂ (r = 0.36, P = .001). The lowest mean Spo₂ varied by 1% between the first and second and second and third doses (P < .001) and was unrelated to clinical classification (P = .40). Minor subjective symptoms were noted by 10 subjects. No serious adverse events occurred.

Conclusion: Hyperpolarized ³He MR imaging can be safely performed in healthy subjects, heavy smokers, and those with severe obstructive airflow limitation, although unpredictable transient desaturation suggests that potential subjects should be carefully screened for comorbidities.

© RSNA, 2008

Materials and Methods: The study was approved by institutional review boards and was HIPAA compliant. Deidentified individual-level data from participants (1520 current or former smokers aged 50–85 years) in the Mayo Clinic helical CT screening study were used to populate the Lung Cancer Policy Model, a comprehensive microsimulation model of lung cancer development, screening findings, treatment results, and long-term outcomes. The model predicted diagnosed cases of lung cancer and deaths per simulated study arm (five annual screening examinations vs no screening). Main outcome measures were predicted changes in lung cancer–specific and all-cause mortality as functions of follow-up time after simulated enrollment and randomization.

Results: At 6-year follow-up, the screening arm had an estimated 37% relative increase in lung cancer detection, compared with the control arm. At 15-year follow-up, five annual screening examinations yielded a 9% relative increase in lung cancer detection. The relative reduction in cumulative lung cancer–specific mortality from five annual screening examinations was 28% at 6-year follow-up (15% at 15 years). The relative reduction in cumulative all-cause mortality from five annual screening examinations was 4% at 6-year follow-up (2% at 15 years).

Conclusion: Screening may reduce lung cancer–specific mortality but may offer a smaller reduction in overall mortality because of increased competing mortality risks associated with smoking.

© RSNA, 2008

Materials and Methods: Institutional review board exemption was granted for this study, which included consenting participants. An electronic survey was sent to members of major thoracic radiology societies in North America, Europe, and Asia. The main part of the survey consisted of four management questions with clinical scenarios. Associations between recommendations and years of experience, location in a region endemic for granulomatous disease, country, and practice type were assessed. Univariate analysis was performed to determine differences in follow-up recommendations on the basis of patient characteristics, percentage of chest CT scans obtained at follow-up, years of experience in radiology, and professional society affiliation of respondents. Differences in categorical variables were examined by using Pearson ² and Fisher exact tests.

Results: Two hundred two (25%) of approximately 800 online surveys were completed. Surveys from respondents from the United States comprised 61% of completed surveys. Median experience of respondents was 11–20 years. Fifty-two percent practice in an area endemic for granulomatous disease. Only 35% of practices have a policy in place for nodule management. In scenarios in which patients had a low likelihood of malignancy, respondents' preferential recommendation was short-term CT follow-up (3–6 months) rather than intermediate-term CT follow-up (12 months) for patients older than 40 years compared with their recommendation in patients younger than 40 years, in whom recommendations for short- or intermediate-term follow-up were roughly equal. In scenarios in which patients had a high risk of malignancy, follow-up was also strongly favored instead of biopsy, with short-term follow-up more commonly advocated. Location in an area endemic for granulomatous disease and years of experience also influenced recommendations.

Conclusion: Globally, the most common recommendation for CT evaluation of nodules is short-term follow-up, with a tendency toward less aggressiveness in scenarios in which patients had lower risk of malignancy and increased aggressiveness in scenarios in which patients had higher risk of malignancy.

© RSNA, 2008

Supplemental material: http://radiology.rsnajnls.org/cgi/content/full/2473061514/DC1

Materials and Methods: This HIPAA-compliant study had institutional review board approval; informed consent was obtained. Five hundred thirty-one consecutive patients were clinically suspected of having PE; 201 were enrolled (72 men, 129 women; median age, 61 years) and underwent CT pulmonary angiography and D-dimer assay. Relevant clinical history, symptoms, and signs were recorded. CT images were interpreted, and the location of emboli was recorded. The negative predictive value (NPV), positive predictive value (PPV), sensitivity, specificity, and diagnostic likelihood ratios of the D-dimer assay results were calculated.

Results: Forty-three patients (21%) had pulmonary emboli at CT. D-Dimer results were positive in 171 patents (85%). The NPV and sensitivity were 97% and 98%, respectively. The specificity and PPV were 18% and 25%, respectively. No association was shown between clinical history, symptoms, or signs and NPV, PPV, sensitivity, or specificity or between location of PE and sensitivity.

Conclusion: D-Dimer results have high NPV and sensitivity for PE in oncologic patients and, if negative, can be used to exclude PE in this population. Combining the assay with clinical symptoms and signs did not substantially change NPV, PPV, sensitivity, or specificity.

© RSNA, 2008

Materials and Methods: For this Ethical Committee–approved study, multi–detector row CT (collimation, 4 x 1 mm; rotation time, 0.5 second; 140 kVp; and 80 effective mAs) was performed in 47 lung transplant recipients (23 women, 24 men; mean age, 41 years ± 12 [standard deviation]; 18 without bronchiolitis, 18 with potential bronchiolitis, and 11 with bronchiolitis, as determined by lung function measurements). Images were reconstructed with a thickness of 1 mm at an increment of 10 mm. The extent of air trapping in the upper, middle, and lower lung regions was correlated. Differences between regions and the interaction between patients and regions were tested with an analysis of variance. The extent of air trapping was calculated for six simulated examination protocols.

Results: Correlations between the upper and middle (r = 0.930), the upper and lower (r = 0.756), and the middle and lower lung regions (r = 0.863) were significant (P < .001). The extent of air trapping increased from the upper to the lower lung region, with significant differences between regions (P < .001). There was a significant interaction between patients and lung regions (P < .001). Simulated examination protocols resulted in significantly different extents of air trapping (P < .001).

Conclusion: The regional distribution of the extent of air trapping in suspected or overt bronchiolitis is heterogeneous. Because the extent of air trapping can depend on the examination protocol, identical protocols are needed when air trapping is being compared within and between patients.

© RSNA, 2008

Materials and Methods: Institutional review board approval was obtained, and the informed consent requirement was waived for this HIPAA-compliant study. Retrospective analysis was performed with 27 consecutive patients (12 male, 15 female; age range, 16–67 years) who underwent MR venography of the central veins. Six radiologists with varying levels of experience interpreted the studies. For each study, the readers were presented with time-resolved maximum intensity projection (MIP) images only, high-spatial-resolution images only, or both. Sensitivity and specificity were calculated for detection of stenoses and occlusions, as well as for confidence levels, study interpretation time, and determination of the side of the body on which upper extremity contrast material injection was performed.

Results: The addition of time-resolved angiographic images to the high-spatial-resolution images resulted in improved specificity in the detection of venous occlusions (0.99 vs 0.96, P = .03), in reader confidence (P < .001), and in the ability to infer the side of injection (83% correct compared with 32% correct, P < .001), without increasing the average time required for study interpretation. Use of time-resolved angiographic data sets as a stand-alone technique had high sensitivity (0.95) but only moderate specificity (0.56) in the detection of venous stenoses or occlusions.

Conclusion: Time-resolved angiographic images are a useful adjunct to high-spatial-resolution images in the evaluation of central venous stenoses and occlusions.

© RSNA, 2008